Cellular Senescence in the Absence of Galactic Cosmic-Ray Muons
RNA-seq (gene expression) · human · 60 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 60 samples: 30 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Cellular Senescence in the Absence of Galactic Cosmic-Ray MuonsAging and disease · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE310137_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1365187 and SRA study SRP645160. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 60 samples.
How we read this: 30 replicated groups read from 60 sample titles; they account for 60 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9289317 A549 cells, proliferative control, day 1, AGL, rep1 A549 cells, proliferati…
- GSM9289318 A549 cells, proliferative control, day 1, AGL, rep2 A549 cells, proliferati…
- GSM9289319 A549 cells, proliferative control, day 1, DUL, rep1 A549 cells, proliferati…
- GSM9289320 A549 cells, proliferative control, day 1, DUL, rep2 A549 cells, proliferati…
- GSM9289321 A549 cells, alisertib 100 nmol/L, day 3, AGL, rep1 A549 cells, alisertib 1…
- GSM9289322 A549 cells, alisertib 100 nmol/L, day 3, AGL, rep2 A549 cells, alisertib 1…
- GSM9289323 A549 cells, alisertib 500 nmol/L, day 3, AGL, rep1 A549 cells, alisertib 5…
- GSM9289324 A549 cells, alisertib 500 nmol/L, day 3, AGL, rep2 A549 cells, alisertib 5…
- GSM9289325 A549 cells, bleomycin 20 umol/L, day 3, AGL, rep1 A549 cells, bleomycin 2…
- GSM9289326 A549 cells, bleomycin 20 umol/L, day 3, AGL, rep2 A549 cells, bleomycin 2…
- GSM9289327 A549 cells, bleomycin 5 umol/L, day 3, AGL, rep1 A549 cells, bleomycin 5…
- GSM9289328 A549 cells, bleomycin 5 umol/L, day 3, AGL, rep2 A549 cells, bleomycin 5…
- GSM9289329 A549 cells, proliferative control, day 3, AGL, rep1 A549 cells, proliferati…
- GSM9289330 A549 cells, proliferative control, day 3, AGL, rep2 A549 cells, proliferati…
- GSM9289331 A549 cells, Palboclib 1 umol/L, day 3, AGL, rep1 A549 cells, Palboclib 1…
- GSM9289332 A549 cells, Palboclib 1 umol/L, day 3, AGL, rep2 A549 cells, Palboclib 1…
- GSM9289333 A549 cells, Palboclib 5 umol/L, day 3, AGL, rep1 A549 cells, Palboclib 5…
- GSM9289334 A549 cells, Palboclib 5 umol/L, day 3, AGL, rep2 A549 cells, Palboclib 5…
- GSM9289335 A549 cells, alisertib 100 nmol/L, day 3, DUL, rep1 A549 cells, alisertib 1…
- GSM9289336 A549 cells, alisertib 100 nmol/L, day 3, DUL, rep2 A549 cells, alisertib 1…
- GSM9289337 A549 cells, alisertib 500 nmol/L, day 3, DUL, rep1 A549 cells, alisertib 5…
- GSM9289338 A549 cells, alisertib 500 nmol/L, day 3, DUL, rep2 A549 cells, alisertib 5…
- GSM9289339 A549 cells, bleomycin 20 umol/L, day 3, DUL, rep1 A549 cells, bleomycin 2…
- GSM9289340 A549 cells, bleomycin 20 umol/L, day 3, DUL, rep2 A549 cells, bleomycin 2…
- GSM9289341 A549 cells, bleomycin 5 umol/L, day 3, DUL, rep1 A549 cells, bleomycin 5…
- GSM9289342 A549 cells, bleomycin 5 umol/L, day 3, DUL, rep2 A549 cells, bleomycin 5…
- GSM9289343 A549 cells, proliferative control, day 3, DUL, rep1 A549 cells, proliferati…
- GSM9289344 A549 cells, proliferative control, day 3, DUL, rep2 A549 cells, proliferati…
- GSM9289345 A549 cells, Palboclib 1 umol/L, day 3, DUL, rep1 A549 cells, Palboclib 1…
- GSM9289346 A549 cells, Palboclib 1 umol/L, day 3, DUL, rep2 A549 cells, Palboclib 1…
- GSM9289347 A549 cells, Palboclib 5 umol/L, day 3, DUL, rep1 A549 cells, Palboclib 5…
- GSM9289348 A549 cells, Palboclib 5 umol/L, day 3, DUL, rep2 A549 cells, Palboclib 5…
- GSM9289349 A549 cells, alisertib 100 nmol/L, day 7, AGL, rep1 A549 cells, alisertib 1…
- GSM9289350 A549 cells, alisertib 100 nmol/L, day 7, AGL, rep2 A549 cells, alisertib 1…
- GSM9289351 A549 cells, alisertib 500 nmol/L, day 7, AGL, rep1 A549 cells, alisertib 5…
- GSM9289352 A549 cells, alisertib 500 nmol/L, day 7, AGL, rep2 A549 cells, alisertib 5…
- GSM9289353 A549 cells, bleomycin 20 umol/L, day 7, AGL, rep1 A549 cells, bleomycin 2…
- GSM9289354 A549 cells, bleomycin 20 umol/L, day 7, AGL, rep2 A549 cells, bleomycin 2…
- GSM9289355 A549 cells, bleomycin 5 umol/L, day 7, AGL, rep1 A549 cells, bleomycin 5…
- GSM9289356 A549 cells, bleomycin 5 umol/L, day 7, AGL, rep2 A549 cells, bleomycin 5…
+ 20 more — browse all 60 samples with per-sample file links →
- GSE268953 Cellular senescence in skeletal muscle aging: new mechanisms and therapeutic potential for sarcopenia [snMultiome_ATAC+GEX] 20 samples shares senescence, cellular
- GSE284666 SenCat: Redefining human cell senescence through multiomic profiling of multiple senescent cell types 190 samples shares senescence
- GSE334651 Alternative splicing- and gene fusion-derived neoepitopes in MASLD-associated hepatocellular carcinoma 120 samples shares cellular
- GSE272681 The cellular hierarchy of acute myeloid leukemia informs personalized treatment 108 samples shares cellular
- GSE208732 Mapping functional to morphological variation reveals the basis of regional extracellular matrix subversion and nerve invasion in pancreatic cancer [RNA-seq] 102 samples shares cellular
- GSE285963 Transcriptome profile of hepatocellular carcinoma in patients with atezolizumab plus bevacizumab therapy. 84 samples shares cellular
- GSE231854 The heterogeneity analysis of hepatocellular carcinoma and combined hepatocellular cholangiocarcinoma 81 samples shares cellular
- GSE281593 Systems Biology-Based Assessment of Immune Responses to Whole Cell and Acellular Pertussis Vaccines: Rationale, Methodology and Enrollment Procedures for Omics Workflows 79 samples shares cellular
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.